Cargando…
Screening for bovine papillomavirus type 13 (BPV13) in a European population of sarcoid‐bearing equids
BACKGROUND: Bovine papillomavirus types 1 and 2 (BPV1 and BPV2) are accepted aetiological agents of equine sarcoids. Recently, genetically similar BPV13 has been identified from equine sarcoids in Brazil. OBJECTIVES: To determine whether BPV13 DNA can be also found in sarcoid‐affected horses in Aust...
Autores principales: | Jindra, Christoph, Kamjunke, Ann‐Kristin, Jones, Sarah, Brandt, Sabine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292424/ https://www.ncbi.nlm.nih.gov/pubmed/34459020 http://dx.doi.org/10.1111/evj.13501 |
Ejemplares similares
-
Influenza virus vector iNS1 expressing bovine papillomavirus 1 (BPV1) antigens efficiently induces tumour regression in equine sarcoid patients
por: Jindra, Christoph, et al.
Publicado: (2021) -
Evidence from a Series of 104 Equine Sarcoids Suggests That Most Sarcoids in New Zealand Are Caused by Bovine Papillomavirus Type 2, although Both BPV1 and BPV2 DNA Are Detectable in around 10% of Sarcoids
por: Munday, John S., et al.
Publicado: (2021) -
CRISPR/Cas9-Mediated Targeting of BPV-1-Transformed Primary Equine Sarcoid Fibroblasts
por: Monod, Anne, et al.
Publicado: (2023) -
Bovine Papillomavirus Type 1 or 2 Virion-Infected Primary Fibroblasts Constitute a Near-Natural Equine Sarcoid Model
por: Hainisch, Edmund K., et al.
Publicado: (2022) -
Immunotherapy of Equine Sarcoids—From Early Approaches to Innovative Vaccines
por: Jindra, Christoph, et al.
Publicado: (2023)